Manufacturer
SANOFI WINTHROP INDUSTRIE
Contents
Lenograstim
Indication
Neutropenia following bone marrow transplantation, Mobilisation of peripheral blood progenitor cells for autologous peripheral blood stem cell transplantation, Chemotherapy-induced neutropenia, Congenital neutropenia.
Instruction
Administer via IV Infusion/Subcutaneous Injection
Drug interaction
Increased risk of pulmonary toxicity w/ bleomycin, cyclophosphamide, methotrexate.
Malaysia
